(Q72810625)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6231452%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Chronic lymphocytic leukemia and hypercalcemia: treatment with dichloromethylene diphosphonate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6231452%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

Case report: Chronic lymphocytic leukemia and hypercalcemia: Treatment with dichloromethylene diphosphonate (English)

1 reference

https://api.crossref.org/works/10.1016/0221-8747(83)90002-4

chronic lymphocytic leukemia

2 September 2023

main subject

1 reference

1 reference

https://api.crossref.org/works/10.1016/0221-8747(83)90002-4

2 September 2023

author name string

E. S. Siris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6231452

2 September 2023

L. Grossbard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6231452

2 September 2023

J. P. Halper

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6231452

2 September 2023

R. S. Blume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6231452

2 September 2023

T. P. Jacobs

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6231452

2 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6231452

2 September 2023

publication date

1 January 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6231452%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

29 October 2019

https://api.elsevier.com/content/article/PII:0221874783900024?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0221-8747(83)90002-4

https://api.elsevier.com/content/article/PII:0221874783900024?httpAccept=text/plain

2 September 2023

1 reference

https://api.crossref.org/works/10.1016/0221-8747(83)90002-4

Metabolic bone disease & related research

2 September 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6231452%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6231452%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6231452%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

61-63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6231452%20AND%20SRC:MED&resulttype=core&format=json

Cell-surface immunoglobulins in chronic lymphocytic leukemia and allied disorders.

29 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0221-8747(83)90002-4

Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases

2 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/0221-8747(83)90002-4

Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease

2 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0221-8747(83)90002-4

Occurrence of surface IgM, IgD, and free light chains of human lymphocytes

2 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0221-8747(83)90002-4

Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate

2 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0221-8747(83)90002-4

Hypercalcaemia and osteolytic bone lesions in chronic lymphocytic leukaemia.

2 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0221-8747(83)90002-4

Pathogenesis of hypercalcemia in lymphosarcoma cell leukemia. Role of an osteoclast activating factor-like substance and a mechanism of action for glucocorticoid therapy

2 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0221-8747(83)90002-4

Evidence for the secretion of an osteoclast stimulating factor in myeloma.

2 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0221-8747(83)90002-4

Hypercalcaemia in Chronic Lymphatic Leukaemia

2 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0221-8747(83)90002-4

Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate

2 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0221-8747(83)90002-4

Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma

2 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0221-8747(83)90002-4

Richter's syndrome: diffuse histiocytic lymphoma in patients with chronic lymphocytic leukemia. A report of five cases and review of the literature

2 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0221-8747(83)90002-4

Primary hyperparathyroidism and chronic lymphocytic leukemia

2 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0221-8747(83)90002-4

2 September 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6231452%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference